{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:54:45Z","timestamp":1786636485475,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0377-4929.97871","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T03:31:47Z","timestamp":1341286307000},"page":"206","source":"Crossref","is-referenced-by-count":8,"title":["Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma"],"prefix":"10.4103","volume":"55","author":[{"given":"S","family":"Varma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VV","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.97871-1","first-page":"260","volume-title":"A closer look at paroxysmal nocturnal hemoglobinuria","author":"Rachidi","year":"2010","journal-title":"Eur J Intern Med"},{"key":"key-10.4103\/0377-4929.97871-2","first-page":"211","volume-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","author":"Borowitz","year":"2010","journal-title":"Cytometry Part B Clin Cytom"},{"key":"key-10.4103\/0377-4929.97871-3","first-page":"470","volume-title":"Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria","author":"Hillmen","year":"2000","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0377-4929.97871-4","first-page":"3699","volume-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.97871-5","unstructured":"Parker CJ, Ware RE. Paroxysmal nocturnal hemoglobinuria. In Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, et al. editors. Wintrobe\u2032s Clinical Hematology. Philadelphia: Lippincott Williams and Wilkins: 2009. p. 998-1020."},{"key":"key-10.4103\/0377-4929.97871-6","first-page":"15s","volume-title":"Prevalence of paroxysmal nocutrnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndromes (MDS), aplastic anemia (AA) or other bone marrow failure (BMF) syndromes: Interim results from the EXPLORE trial","author":"Galili","year":"2009","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.97871-7","first-page":"1354","volume-title":"Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link","author":"Griscelli-Bennaceur","year":"1995","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.97871-8","first-page":"401","volume-title":"Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes","author":"Dunn","year":"1999","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0377-4929.97871-9","first-page":"13","volume-title":"The PNH abnormality in myeloproliferative disorders: Association of PNH and acute erythremic myelosis in two children","author":"Luzzatto","year":"1979","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.97871-10","first-page":"33","volume-title":"Detection of CD55 and\/or CD59- deficient red cell population in patients with lymphoproliferative syndromes","author":"Meletis","year":"2001","journal-title":"Hematol J"},{"key":"key-10.4103\/0377-4929.97871-11","first-page":"40","volume-title":"Detection of CD55 and\/or CD59- deficient red cell population in patients with plasma cell dyscrasias","author":"Meletis","year":"2002","journal-title":"Int J Hematol"},{"key":"key-10.4103\/0377-4929.97871-12","first-page":"395","volume-title":"Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (CMP) and CD55 (DAF) in hematological malignancies","author":"Seya","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/0377-4929.97871-13","first-page":"344","volume-title":"Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma","author":"Terpos","year":"2003","journal-title":"Int J Hematol"},{"key":"key-10.4103\/0377-4929.97871-14","first-page":"177","volume-title":"Detection of \u2032PNH Red Cell\u2032 populations in hematological disorders using the sephacryl gel test micro typing system","author":"Meletis","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/0377-4929.97871-15","first-page":"236","volume-title":"Chronic lymphocytic leukemia: Recommendations for diagnosis, staging and response criteria","author":"International","year":"1989","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0377-4929.97871-16","first-page":"410","volume-title":"UK Myeloma Forum; Nordic Myeloma Study Group; British Committee for Standards in Haematology.Guidelines on the diagnosis and management of Multiple Myeloma 2005","author":"Smith","year":"2006","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0377-4929.97871-17","first-page":"198","volume-title":"A new prognostic classification of CLL derived from a multivariate survival analysis","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"key-10.4103\/0377-4929.97871-18","first-page":"842","volume-title":"A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"key-10.4103\/0377-4929.97871-19","first-page":"247","volume-title":"Detection of small population of CD59 deficient erythrocytes in patients with aplastic anemia and myelodysplastic syndrome and normal individuals","author":"Mitsuhiro","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"key-10.4103\/0377-4929.97871-20","doi-asserted-by":"crossref","unstructured":"Lewis SM, Roper D. Laboratory methods used in the investigation of haemolytic anemias. In: Lewis SM, Bain BJ, Bates I, editors. Dacie and Lewis Practical Hematology. Philadelphia: Churchill Livingstone; 2006. p. 188-90.","DOI":"10.1016\/B0-44-306660-4\/50013-1"},{"key":"key-10.4103\/0377-4929.97871-21","unstructured":"Lewis SM, Bain BJ, Win N. Acquired haemolytic anemias. In: Lewis SM, Bain BJ, Bates I, editors. Dacie and Lewis Practical Hematology. Philadelphia: Churchill Livingstone; 2006. p. 260-70."},{"key":"key-10.4103\/0377-4929.97871-22","first-page":"969","volume-title":"Mechanisms by which surface expression of the glycosyl-phosphatidyl inositol anchored complement regulatory proteins CD55 and CD59 is lost in human leukemia cell lines","author":"Hatanaka","year":"1996","journal-title":"Biochem J"},{"key":"key-10.4103\/0377-4929.97871-23","first-page":"1487","volume-title":"Emergence of CD52- phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma","author":"Hertenstein","year":"1995","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.97871-24","first-page":"122","volume-title":"Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient","author":"Kulagin","year":"2008","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0377-4929.97871-25","first-page":"628","volume-title":"Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting","author":"Sun","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0377-4929.97871-26","first-page":"3897","volume-title":"Clinical significance of a minor population of PNH-type cells in Bone marrow failure syndrome","author":"Wang","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.97871-27","first-page":"81","volume-title":"A standardized flow cytometric method for screening paroxysmal nocturnal hemoglobinuria measuring CD55 and CD59 expression on erythrocytes and granulocytes","author":"Oelschlagel","year":"2001","journal-title":"Clin Lab Haematol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:57:41Z","timestamp":1786633061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0377-4929.97871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["97871"],"URL":"https:\/\/doi.org\/10.4103\/0377-4929.97871","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}